| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catecholamine binding | 4.92e-07 | 13 | 25 | 3 | GO:1901338 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gs | 1.50e-06 | 2 | 25 | 2 | GO:0001588 | |
| GeneOntologyMolecularFunction | bradykinin receptor binding | 4.51e-06 | 3 | 25 | 2 | GO:0031711 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 7.89e-06 | 884 | 25 | 8 | GO:0004930 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 1.50e-05 | 5 | 25 | 2 | GO:0004952 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 2.07e-05 | 43 | 25 | 3 | GO:0001965 | |
| GeneOntologyMolecularFunction | dopamine binding | 3.15e-05 | 7 | 25 | 2 | GO:0035240 | |
| GeneOntologyMolecularFunction | symporter activity | 3.42e-05 | 150 | 25 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.16e-04 | 13 | 25 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 1.66e-04 | 1353 | 25 | 8 | GO:0004888 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.31e-04 | 119 | 25 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.50e-04 | 293 | 25 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.68e-04 | 296 | 25 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | dopamine receptor binding | 4.80e-04 | 26 | 25 | 2 | GO:0050780 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.97e-04 | 133 | 25 | 3 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 6.93e-04 | 140 | 25 | 3 | GO:0001653 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 7.29e-04 | 32 | 25 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 7.62e-04 | 337 | 25 | 4 | GO:0001664 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 2.46e-03 | 59 | 25 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.73e-03 | 477 | 25 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.82e-03 | 1180 | 25 | 6 | GO:0022857 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.95e-03 | 75 | 25 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | transporter activity | 4.37e-03 | 1289 | 25 | 6 | GO:0005215 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.59e-03 | 81 | 25 | 2 | GO:0015370 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 6.10e-03 | 301 | 25 | 3 | GO:0022853 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 6.91e-03 | 100 | 25 | 2 | GO:0030594 | |
| GeneOntologyMolecularFunction | hormone binding | 7.32e-03 | 103 | 25 | 2 | GO:0042562 | |
| GeneOntologyMolecularFunction | cytokine binding | 1.64e-02 | 157 | 25 | 2 | GO:0019955 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.92e-02 | 171 | 25 | 2 | GO:0015081 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.97e-02 | 465 | 25 | 3 | GO:0046873 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 4.01e-06 | 25 | 26 | 3 | GO:0071880 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 1.01e-05 | 109 | 26 | 4 | GO:1904427 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 1.04e-05 | 34 | 26 | 3 | GO:0007190 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 1.13e-05 | 35 | 26 | 3 | GO:0071875 | |
| GeneOntologyBiologicalProcess | sensitization | 1.52e-05 | 5 | 26 | 2 | GO:0046960 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 1.70e-05 | 40 | 26 | 3 | GO:0045762 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 2.21e-05 | 133 | 26 | 4 | GO:0007200 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 2.96e-05 | 48 | 26 | 3 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 3.15e-05 | 49 | 26 | 3 | GO:0051349 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure by epinephrine-norepinephrine | 3.20e-05 | 7 | 26 | 2 | GO:0003321 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 3.93e-05 | 154 | 26 | 4 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 4.26e-05 | 8 | 26 | 2 | GO:0001993 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 5.37e-05 | 334 | 26 | 5 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 5.37e-05 | 334 | 26 | 5 | GO:0001894 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating dopamine receptor signaling pathway | 5.47e-05 | 9 | 26 | 2 | GO:0060158 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 5.52e-05 | 59 | 26 | 3 | GO:0045777 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 5.52e-05 | 59 | 26 | 3 | GO:0045761 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 6.10e-05 | 61 | 26 | 3 | GO:0003044 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 6.33e-05 | 174 | 26 | 4 | GO:1904064 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 8.82e-05 | 69 | 26 | 3 | GO:0031279 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 9.08e-05 | 191 | 26 | 4 | GO:0007189 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 9.27e-05 | 192 | 26 | 4 | GO:0034767 | |
| GeneOntologyBiologicalProcess | response to catecholamine | 1.04e-04 | 73 | 26 | 3 | GO:0071869 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 1.04e-04 | 73 | 26 | 3 | GO:0051339 | |
| GeneOntologyBiologicalProcess | response to monoamine | 1.09e-04 | 74 | 26 | 3 | GO:0071867 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 1.09e-04 | 922 | 26 | 7 | GO:0098662 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 1.13e-04 | 202 | 26 | 4 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 1.13e-04 | 202 | 26 | 4 | GO:0035296 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 1.15e-04 | 203 | 26 | 4 | GO:0035150 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion import across plasma membrane | 1.18e-04 | 13 | 26 | 2 | GO:1905665 | |
| GeneOntologyBiologicalProcess | nonassociative learning | 1.18e-04 | 13 | 26 | 2 | GO:0046958 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating dopamine receptor signaling pathway | 1.18e-04 | 13 | 26 | 2 | GO:0007191 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 1.24e-04 | 942 | 26 | 7 | GO:0098655 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.49e-04 | 217 | 26 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 1.51e-04 | 218 | 26 | 4 | GO:1903169 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.80e-04 | 1000 | 26 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 2.00e-04 | 1017 | 26 | 7 | GO:0098660 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 2.00e-04 | 705 | 26 | 6 | GO:0055080 | |
| GeneOntologyBiologicalProcess | diet induced thermogenesis | 2.05e-04 | 17 | 26 | 2 | GO:0002024 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 2.19e-04 | 717 | 26 | 6 | GO:0050801 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 2.23e-04 | 1395 | 26 | 8 | GO:0007186 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | 2.34e-04 | 1043 | 26 | 7 | GO:0048871 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion import across plasma membrane | 2.58e-04 | 19 | 26 | 2 | GO:1905664 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 3.23e-04 | 266 | 26 | 4 | GO:0043270 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 3.51e-04 | 1115 | 26 | 7 | GO:0034220 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 3.57e-04 | 273 | 26 | 4 | GO:0034764 | |
| GeneOntologyBiologicalProcess | grooming behavior | 4.15e-04 | 24 | 26 | 2 | GO:0007625 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 4.25e-04 | 286 | 26 | 4 | GO:0007188 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 4.40e-04 | 1157 | 26 | 7 | GO:0006812 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 4.64e-04 | 121 | 26 | 3 | GO:0042310 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | 4.98e-04 | 124 | 26 | 3 | GO:0003073 | |
| GeneOntologyBiologicalProcess | associative learning | 5.72e-04 | 130 | 26 | 3 | GO:0008306 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 6.72e-04 | 323 | 26 | 4 | GO:0051924 | |
| GeneOntologyBiologicalProcess | behavior | 7.00e-04 | 891 | 26 | 6 | GO:0007610 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 7.40e-04 | 142 | 26 | 3 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 7.40e-04 | 142 | 26 | 3 | GO:0098659 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion import | 8.36e-04 | 34 | 26 | 2 | GO:0090280 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 8.50e-04 | 344 | 26 | 4 | GO:0003018 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 8.81e-04 | 611 | 26 | 5 | GO:0030003 | |
| GeneOntologyBiologicalProcess | synaptic transmission, dopaminergic | 8.86e-04 | 35 | 26 | 2 | GO:0001963 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 9.54e-04 | 622 | 26 | 5 | GO:0006873 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 9.54e-04 | 622 | 26 | 5 | GO:0098771 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 1.04e-03 | 38 | 26 | 2 | GO:0015701 | |
| GeneOntologyBiologicalProcess | feeding behavior | 1.08e-03 | 162 | 26 | 3 | GO:0007631 | |
| GeneOntologyBiologicalProcess | response to amphetamine | 1.16e-03 | 40 | 26 | 2 | GO:0001975 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 1.23e-03 | 1374 | 26 | 7 | GO:0006811 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 1.23e-03 | 380 | 26 | 4 | GO:1904062 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 1.25e-03 | 382 | 26 | 4 | GO:0009416 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.38e-03 | 392 | 26 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | G protein-coupled dopamine receptor signaling pathway | 1.40e-03 | 44 | 26 | 2 | GO:0007212 | |
| GeneOntologyBiologicalProcess | long-term synaptic depression | 1.40e-03 | 44 | 26 | 2 | GO:0060292 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.46e-03 | 45 | 26 | 2 | GO:0048521 | |
| GeneOntologyBiologicalProcess | response to dietary excess | 1.60e-03 | 47 | 26 | 2 | GO:0002021 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.66e-03 | 48 | 26 | 2 | GO:0098703 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 1.66e-03 | 48 | 26 | 2 | GO:0051281 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.66e-03 | 48 | 26 | 2 | GO:1902656 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 1.73e-03 | 417 | 26 | 4 | GO:0034765 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by hormone | 1.88e-03 | 51 | 26 | 2 | GO:0001990 | |
| GeneOntologyBiologicalProcess | triglyceride biosynthetic process | 1.95e-03 | 52 | 26 | 2 | GO:0019432 | |
| GeneOntologyBiologicalProcess | dopamine metabolic process | 2.02e-03 | 53 | 26 | 2 | GO:0042417 | |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion transport | 2.10e-03 | 54 | 26 | 2 | GO:0043268 | |
| GeneOntologyBiologicalProcess | mitochondrial transport | 2.13e-03 | 205 | 26 | 3 | GO:0006839 | |
| GeneOntologyBiologicalProcess | eating behavior | 2.26e-03 | 56 | 26 | 2 | GO:0042755 | |
| GeneOntologyBiologicalProcess | mating behavior | 2.34e-03 | 57 | 26 | 2 | GO:0007617 | |
| GeneOntologyBiologicalProcess | learning | 2.34e-03 | 212 | 26 | 3 | GO:0007612 | |
| GeneOntologyBiologicalProcess | response to amine | 2.42e-03 | 58 | 26 | 2 | GO:0014075 | |
| HumanPheno | Orthokeratotic hyperkeratosis | 8.85e-05 | 7 | 11 | 2 | HP:0025080 | |
| Domain | 7TM_GPCR_Srsx | 8.48e-09 | 112 | 26 | 6 | SM01381 | |
| Domain | GPCR_Rhodpsn_7TM | 2.32e-06 | 670 | 26 | 8 | IPR017452 | |
| Domain | 7tm_1 | 2.50e-06 | 677 | 26 | 8 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.73e-06 | 685 | 26 | 8 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 2.91e-06 | 691 | 26 | 8 | PS50262 | |
| Domain | GPCR_Rhodpsn | 2.95e-06 | 692 | 26 | 8 | IPR000276 | |
| Domain | Dopamine_rcpt | 1.86e-05 | 5 | 26 | 2 | IPR000929 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 6.25e-08 | 260 | 21 | 7 | M39397 | |
| Pathway | WP_GPCRS_NONODORANT | 7.30e-08 | 266 | 21 | 7 | MM15843 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 3.17e-07 | 330 | 21 | 7 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 3.37e-07 | 333 | 21 | 7 | MM14963 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.88e-06 | 430 | 21 | 7 | MM15160 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.08e-06 | 272 | 21 | 6 | M13380 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 3.07e-06 | 463 | 21 | 7 | M507 | |
| Pathway | WP_GPCRS_PEPTIDE | 3.13e-06 | 70 | 21 | 4 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 4.13e-06 | 75 | 21 | 4 | M39696 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 6.50e-06 | 186 | 21 | 5 | MM15994 | |
| Pathway | WP_GPCRS_OTHER | 1.11e-05 | 96 | 21 | 4 | MM15939 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.16e-05 | 367 | 21 | 6 | M48346 | |
| Pathway | WP_MONOAMINE_GPCRS | 1.25e-05 | 31 | 21 | 3 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 1.51e-05 | 33 | 21 | 3 | M39585 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 2.11e-05 | 5 | 21 | 2 | M27301 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 2.11e-05 | 5 | 21 | 2 | MM15007 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 2.72e-05 | 646 | 21 | 7 | MM14962 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 3.15e-05 | 42 | 21 | 3 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 3.15e-05 | 42 | 21 | 3 | MM14971 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 4.64e-05 | 702 | 21 | 7 | M746 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 5.31e-05 | 143 | 21 | 4 | MM15055 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 7.64e-05 | 157 | 21 | 4 | M4904 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.24e-04 | 178 | 21 | 4 | M2890 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.84e-04 | 197 | 21 | 4 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.84e-04 | 197 | 21 | 4 | MM14970 | |
| Pathway | PID_ARF6_PATHWAY | 1.22e-03 | 35 | 21 | 2 | M86 | |
| Pathway | PID_ARF6_TRAFFICKING_PATHWAY | 2.38e-03 | 49 | 21 | 2 | M67 | |
| Pubmed | Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. | 3.71e-10 | 3 | 26 | 3 | 18172057 | |
| Pubmed | Redundant catecholamine signaling consolidates fear memory via phospholipase C. | 3.70e-09 | 5 | 26 | 3 | 22323706 | |
| Pubmed | 7.02e-09 | 200 | 26 | 6 | 18240029 | ||
| Pubmed | 2.18e-07 | 70 | 26 | 4 | 12036966 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21893192 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26763483 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26174222 | ||
| Pubmed | PV plasticity sustained through D1/5 dopamine signaling required for long-term memory consolidation. | 5.37e-07 | 2 | 26 | 2 | 26807952 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 19786093 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24552847 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 19279248 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26186971 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 20708651 | ||
| Pubmed | Differential roles of the dopamine 1-class receptors, D1R and D5R, in hippocampal dependent memory. | 5.37e-07 | 2 | 26 | 2 | 24843151 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 1831904 | ||
| Pubmed | Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. | 5.37e-07 | 2 | 26 | 2 | 13679419 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25429131 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 19204052 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25154512 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11823893 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 18464932 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 20180564 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11500503 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7609904 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19171671 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 22710646 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 21115476 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 25339698 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 29407371 | ||
| Pubmed | Aging-related dysregulation of dopamine and angiotensin receptor interaction. | 1.61e-06 | 3 | 26 | 2 | 24529758 | |
| Pubmed | Dopamine receptor genes and migraine with and without aura: an association study. | 1.61e-06 | 3 | 26 | 2 | 12047334 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 12867509 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 22466342 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 16962565 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 20164562 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 12967601 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 29541380 | ||
| Pubmed | Dopamine genes and pathological gambling in discordant sib-pairs. | 3.22e-06 | 4 | 26 | 2 | 17394052 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 25049074 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 24727057 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 18403039 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 9457173 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 19266703 | ||
| Pubmed | [Dopamine receptor signaling regulates human osteoclastogenesis]. | 5.37e-06 | 5 | 26 | 2 | 23445730 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 25560761 | ||
| Pubmed | Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes. | 5.37e-06 | 5 | 26 | 2 | 22219295 | |
| Pubmed | The central melanocortin system directly controls peripheral lipid metabolism. | 5.37e-06 | 5 | 26 | 2 | 17885689 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 18679149 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 26597879 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 19105202 | ||
| Pubmed | Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. | 5.37e-06 | 5 | 26 | 2 | 12509874 | |
| Pubmed | Dopamine receptor loss of function is not protective of rd1 rod photoreceptors in vivo. | 5.37e-06 | 5 | 26 | 2 | 20038975 | |
| Pubmed | Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. | 5.37e-06 | 5 | 26 | 2 | 12486173 | |
| Pubmed | Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain. | 5.37e-06 | 5 | 26 | 2 | 20714340 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 23753418 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 17509542 | ||
| Pubmed | Molecular pharmacology and modeling of vasopressin receptors. | 5.37e-06 | 5 | 26 | 2 | 12436935 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 18083900 | ||
| Pubmed | 8.00e-06 | 52 | 26 | 3 | 8288218 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 17223428 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 10205143 | ||
| Pubmed | Noradrenergic signaling mediates cortical early tagging and storage of remote memory. | 8.05e-06 | 6 | 26 | 2 | 36494350 | |
| Pubmed | Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. | 8.05e-06 | 6 | 26 | 2 | 21982372 | |
| Pubmed | Retinal dopamine mediates multiple dimensions of light-adapted vision. | 8.05e-06 | 6 | 26 | 2 | 22764243 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 16893516 | ||
| Pubmed | DISC1 regulates primary cilia that display specific dopamine receptors. | 8.05e-06 | 6 | 26 | 2 | 20531939 | |
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 9.91e-06 | 182 | 26 | 4 | 20468064 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 16615274 | ||
| Pubmed | Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. | 1.13e-05 | 7 | 26 | 2 | 12394950 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 23312282 | ||
| Pubmed | Mapping of the ACTH, MSH, and neural (MC3 and MC4) melanocortin receptors in the mouse and human. | 1.50e-05 | 8 | 26 | 2 | 7949735 | |
| Pubmed | Two-stage case-control association study of dopamine-related genes and migraine. | 1.93e-05 | 9 | 26 | 2 | 19772578 | |
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 16525059 | ||
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 18413308 | ||
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 12777963 | ||
| Pubmed | Leptin regulation of bone resorption by the sympathetic nervous system and CART. | 2.41e-05 | 10 | 26 | 2 | 15724149 | |
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 21083670 | ||
| Pubmed | 2.94e-05 | 11 | 26 | 2 | 18855532 | ||
| Pubmed | Impact of genomic polymorphism on arterial hypertension after aortic coarctation repair. | 2.94e-05 | 11 | 26 | 2 | 20537417 | |
| Pubmed | Support for association between ADHD and two candidate genes: NET1 and DRD1. | 2.94e-05 | 11 | 26 | 2 | 15717291 | |
| Pubmed | 2.94e-05 | 11 | 26 | 2 | 19779464 | ||
| Pubmed | 3.53e-05 | 12 | 26 | 2 | 20308035 | ||
| Pubmed | Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. | 4.17e-05 | 13 | 26 | 2 | 18937294 | |
| Pubmed | 4.86e-05 | 14 | 26 | 2 | 1354640 | ||
| Pubmed | 4.86e-05 | 14 | 26 | 2 | 24036309 | ||
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | 4.98e-05 | 275 | 26 | 4 | 20734064 | |
| Pubmed | 5.61e-05 | 15 | 26 | 2 | 26053317 | ||
| Pubmed | 6.41e-05 | 16 | 26 | 2 | 15824464 | ||
| Pubmed | 6.98e-05 | 300 | 26 | 4 | 19086053 | ||
| Pubmed | 7.19e-05 | 108 | 26 | 3 | 19956635 | ||
| Pubmed | 8.16e-05 | 18 | 26 | 2 | 8521822 | ||
| Pubmed | 8.16e-05 | 18 | 26 | 2 | 19367093 | ||
| Pubmed | Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. | 9.12e-05 | 117 | 26 | 3 | 18996102 | |
| Pubmed | 1.12e-04 | 21 | 26 | 2 | 15452121 | ||
| Pubmed | 1.12e-04 | 21 | 26 | 2 | 18270970 | ||
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.19e-04 | 128 | 26 | 3 | 19058789 | |
| Pubmed | 1.23e-04 | 22 | 26 | 2 | 11994280 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 1.25e-04 | 130 | 26 | 3 | 19874574 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 1.48e-04 | 697 | 26 | 5 | 28298427 | |
| Pubmed | 1.58e-04 | 141 | 26 | 3 | 18636124 | ||
| Interaction | DNAJC14 interactions | 3.18e-05 | 50 | 25 | 3 | int:DNAJC14 | |
| Interaction | PTGER1 interactions | 6.61e-05 | 10 | 25 | 2 | int:PTGER1 | |
| Interaction | JKAMP interactions | 1.33e-04 | 14 | 25 | 2 | int:JKAMP | |
| GeneFamily | Dopamine receptors | 1.41e-05 | 5 | 22 | 2 | 181 | |
| GeneFamily | Solute carriers | 9.40e-05 | 395 | 22 | 5 | 752 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.01e-06 | 132 | 26 | 4 | dbc0a332fd8f63ebdcf9716e45d7f46f26509349 | |
| Computational | Genes in the cancer module 146. | 9.49e-05 | 102 | 10 | 3 | MODULE_146 | |
| Computational | Genes in the cancer module 288. | 5.10e-04 | 37 | 10 | 2 | MODULE_288 | |
| Drug | 1,1-diphenylethylene | 4.61e-08 | 7 | 26 | 3 | CID000010740 | |
| Drug | DO 710 | 1.58e-07 | 10 | 26 | 3 | CID003084985 | |
| Drug | AC1L1CM5 | 2.17e-07 | 11 | 26 | 3 | CID000001961 | |
| Drug | Bulbokaprin | 3.75e-07 | 13 | 26 | 3 | CID000009276 | |
| Drug | A68930 | 4.77e-07 | 14 | 26 | 3 | CID000122324 | |
| Drug | benzimidazol-2-one | 4.77e-07 | 14 | 26 | 3 | CID000162542 | |
| Drug | A 86929 | 5.96e-07 | 15 | 26 | 3 | ctd:C095427 | |
| Drug | HV723 | 5.96e-07 | 15 | 26 | 3 | CID003081094 | |
| Drug | delta H | 7.33e-07 | 16 | 26 | 3 | CID000034771 | |
| Drug | morphine hydrochloride | 8.35e-07 | 481 | 26 | 7 | CID000004253 | |
| Drug | AMPT | 1.07e-06 | 18 | 26 | 3 | CID000002112 | |
| Drug | fenoldopam | 1.16e-06 | 70 | 26 | 4 | CID000003340 | |
| Drug | columbamine | 1.25e-06 | 2 | 26 | 2 | CID000072309 | |
| Drug | dehydrocorybulbine | 1.25e-06 | 2 | 26 | 2 | CID005316439 | |
| Drug | zelandopam | 1.25e-06 | 2 | 26 | 2 | CID003078104 | |
| Drug | EXP985 | 1.25e-06 | 2 | 26 | 2 | CID000132735 | |
| Drug | tetrahydrocolumbamine | 1.25e-06 | 2 | 26 | 2 | CID000010220 | |
| Drug | SB 200646A | 1.27e-06 | 19 | 26 | 3 | CID000126769 | |
| Drug | DAS-431 | 1.73e-06 | 21 | 26 | 3 | CID000166543 | |
| Drug | pseudococaine | 2.58e-06 | 570 | 26 | 7 | CID000002826 | |
| Drug | 5,6-dihydroxy-2-dimethylaminotetralin | 2.63e-06 | 24 | 26 | 3 | CID000037032 | |
| Drug | ibopamine | 2.63e-06 | 24 | 26 | 3 | CID000068555 | |
| Drug | epinine | 2.63e-06 | 24 | 26 | 3 | CID000004382 | |
| Drug | tardan | 3.38e-06 | 26 | 26 | 3 | CID000002729 | |
| Drug | piperoxan | 3.38e-06 | 26 | 26 | 3 | CID000006040 | |
| Drug | AC1LR3WA | 3.76e-06 | 3 | 26 | 2 | CID001361946 | |
| Drug | Berupipam | 3.76e-06 | 3 | 26 | 2 | CID000066002 | |
| Drug | carphenazine | 3.76e-06 | 3 | 26 | 2 | CID000018104 | |
| Drug | U-99363E | 3.76e-06 | 3 | 26 | 2 | CID000133107 | |
| Drug | Carphenazine | 3.76e-06 | 3 | 26 | 2 | DB01038 | |
| Drug | ecopipam | 3.76e-06 | 3 | 26 | 2 | ctd:C058081 | |
| Drug | roxindole | 4.25e-06 | 28 | 26 | 3 | CID000219050 | |
| Drug | dopexamine | 6.41e-06 | 32 | 26 | 3 | CID000055483 | |
| Drug | DB921 | 7.05e-06 | 33 | 26 | 3 | CID005327049 | |
| Drug | dimethocaine | 7.51e-06 | 4 | 26 | 2 | CID000007177 | |
| Drug | MK-458 | 7.51e-06 | 4 | 26 | 2 | CID000057532 | |
| Drug | SCH 40853 | 7.51e-06 | 4 | 26 | 2 | CID003035575 | |
| Drug | DK-118 | 7.51e-06 | 4 | 26 | 2 | CID000145953 | |
| Drug | U 101958 | 7.51e-06 | 4 | 26 | 2 | CID005311492 | |
| Drug | transdihydrolisuride | 7.73e-06 | 34 | 26 | 3 | CID000005406 | |
| Drug | fluspirilene | 7.73e-06 | 34 | 26 | 3 | CID000003396 | |
| Drug | 1H-3 | 1.09e-05 | 38 | 26 | 3 | CID000043849 | |
| Drug | APAs | 1.18e-05 | 39 | 26 | 3 | CID000004649 | |
| Drug | SCH 24518 | 1.25e-05 | 5 | 26 | 2 | CID000146265 | |
| Drug | DH97 | 1.25e-05 | 5 | 26 | 2 | CID003467177 | |
| Drug | AMMTC | 1.25e-05 | 5 | 26 | 2 | CID005311004 | |
| Drug | tilozepine | 1.25e-05 | 5 | 26 | 2 | CID000172286 | |
| Drug | 2-di-n-propylaminoindan | 1.25e-05 | 5 | 26 | 2 | CID000130402 | |
| Drug | mezilamine | 1.25e-05 | 5 | 26 | 2 | CID000068678 | |
| Drug | C9H11N3O2 | 1.25e-05 | 5 | 26 | 2 | CID000123703 | |
| Drug | NNC-687 | 1.25e-05 | 5 | 26 | 2 | CID000164252 | |
| Drug | SKF 77434 | 1.25e-05 | 5 | 26 | 2 | CID000001241 | |
| Drug | proterguride | 1.25e-05 | 5 | 26 | 2 | CID000071999 | |
| Drug | NO 756 | 1.25e-05 | 5 | 26 | 2 | CID000129967 | |
| Drug | Levodopa | 1.25e-05 | 5 | 26 | 2 | DB01235 | |
| Drug | SKF 82957 | 1.25e-05 | 5 | 26 | 2 | CID000130844 | |
| Drug | SKF85174 | 1.25e-05 | 5 | 26 | 2 | CID000132435 | |
| Drug | corydaline | 1.25e-05 | 5 | 26 | 2 | CID000101301 | |
| Drug | l-CSL | 1.25e-05 | 5 | 26 | 2 | CID006918538 | |
| Drug | 3-iodobenzamide | 1.25e-05 | 5 | 26 | 2 | CID000202425 | |
| Drug | dihydrexidine | 1.25e-05 | 5 | 26 | 2 | ctd:C061532 | |
| Drug | dazopride | 1.25e-05 | 5 | 26 | 2 | CID000054801 | |
| Drug | Fenoldopam | 1.25e-05 | 5 | 26 | 2 | DB00800 | |
| Drug | azapride | 1.25e-05 | 5 | 26 | 2 | CID003036441 | |
| Drug | piquindone | 1.25e-05 | 5 | 26 | 2 | CID000121903 | |
| Drug | A 68930 | 1.25e-05 | 5 | 26 | 2 | ctd:C065380 | |
| Drug | NSC95090 | 1.27e-05 | 40 | 26 | 3 | CID000003251 | |
| Drug | olanzapine | 1.33e-05 | 129 | 26 | 4 | CID000004585 | |
| Drug | DAR-0100A | 1.37e-05 | 41 | 26 | 3 | CID000060759 | |
| Drug | spiroxatrine | 1.47e-05 | 42 | 26 | 3 | CID000005268 | |
| Drug | nisoxetine | 1.47e-05 | 42 | 26 | 3 | CID000004500 | |
| Drug | NSD-1015 | 1.58e-05 | 43 | 26 | 3 | CID000001663 | |
| Drug | 2'-ISP | 1.88e-05 | 6 | 26 | 2 | CID000128389 | |
| Drug | Rotigotine | 1.88e-05 | 6 | 26 | 2 | DB05271 | |
| Drug | pyrazole-3 | 1.88e-05 | 6 | 26 | 2 | CID000354929 | |
| Drug | Zuclopenthixol | 1.88e-05 | 6 | 26 | 2 | DB01624 | |
| Drug | pergolide sulfone | 1.88e-05 | 6 | 26 | 2 | CID000155750 | |
| Drug | pergolide sulfoxide | 1.88e-05 | 6 | 26 | 2 | CID000155749 | |
| Drug | Sch-38548 | 1.88e-05 | 6 | 26 | 2 | CID000130519 | |
| Drug | A66359 | 1.88e-05 | 6 | 26 | 2 | CID000173657 | |
| Drug | CI-943 | 1.88e-05 | 6 | 26 | 2 | CID000146009 | |
| Drug | AC1L1JFX | 1.88e-05 | 6 | 26 | 2 | CID000005023 | |
| Drug | propylbutyldopamine | 1.88e-05 | 6 | 26 | 2 | CID000156067 | |
| Drug | N,N-dimethyldopamine | 1.88e-05 | 6 | 26 | 2 | CID000152427 | |
| Drug | oxiperomide | 1.88e-05 | 6 | 26 | 2 | CID000068634 | |
| Drug | AC1L1I8U | 1.88e-05 | 6 | 26 | 2 | CID000055036 | |
| Drug | LON-954 | 1.88e-05 | 6 | 26 | 2 | CID006441097 | |
| Drug | p-bromospiperone | 1.88e-05 | 6 | 26 | 2 | CID000156386 | |
| Drug | MDO-NPA | 1.88e-05 | 6 | 26 | 2 | CID000133642 | |
| Drug | LY293284 | 1.88e-05 | 6 | 26 | 2 | CID000132345 | |
| Drug | 7-hydroxyamoxapine | 1.88e-05 | 6 | 26 | 2 | CID000162242 | |
| Drug | BAM-1110 | 1.88e-05 | 6 | 26 | 2 | CID003064755 | |
| Drug | 5,6-ADTN | 1.88e-05 | 6 | 26 | 2 | CID000037630 | |
| Drug | ethylamine hydrochloride | 1.88e-05 | 6 | 26 | 2 | CID000011198 | |
| Drug | AC1MI81B | 1.88e-05 | 6 | 26 | 2 | CID003039938 | |
| Drug | HW-165 | 1.88e-05 | 6 | 26 | 2 | CID000125677 | |
| Drug | GBR 13098 | 1.88e-05 | 6 | 26 | 2 | CID000132672 | |
| Drug | flupenthixol decanoate | 1.88e-05 | 6 | 26 | 2 | CID006434100 | |
| Drug | Phenethylamines | 1.88e-05 | 6 | 26 | 2 | ctd:D010627 | |
| Drug | abeorphine | 1.88e-05 | 6 | 26 | 2 | CID000133849 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 3.93e-05 | 75 | 26 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.95e-05 | 447 | 26 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | longitudinal BMI measurement | 5.14e-05 | 82 | 26 | 3 | EFO_0005937 | |
| Disease | Alzheimer's disease (is_marker_for) | 7.23e-05 | 257 | 26 | 4 | DOID:10652 (is_marker_for) | |
| Disease | Huntington's disease (biomarker_via_orthology) | 8.89e-05 | 16 | 26 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | hypertension (is_implicated_in) | 1.63e-04 | 121 | 26 | 3 | DOID:10763 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 1.71e-04 | 22 | 26 | 2 | DOID:12930 (biomarker_via_orthology) | |
| Disease | depressive disorder (implicated_via_orthology) | 1.71e-04 | 22 | 26 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | anti-basement membrane glomerulonephritis (biomarker_via_orthology) | 3.20e-04 | 30 | 26 | 2 | DOID:4780 (biomarker_via_orthology) | |
| Disease | obese body mass index status | 3.88e-04 | 33 | 26 | 2 | EFO_0007041 | |
| Disease | Parkinson disease, disease progression measurement | 5.42e-04 | 39 | 26 | 2 | EFO_0008336, MONDO_0005180 | |
| Disease | congestive heart failure (implicated_via_orthology) | 5.99e-04 | 41 | 26 | 2 | DOID:6000 (implicated_via_orthology) | |
| Disease | metabolic syndrome | 7.11e-04 | 200 | 26 | 3 | EFO_0000195 | |
| Disease | depressive disorder (biomarker_via_orthology) | 9.64e-04 | 52 | 26 | 2 | DOID:1596 (biomarker_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 1.03e-03 | 227 | 26 | 3 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Insulin Sensitivity | 1.28e-03 | 60 | 26 | 2 | C0920563 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 1.28e-03 | 60 | 26 | 2 | MONDO_0005148, MONDO_0005277 | |
| Disease | Insulin Resistance | 1.28e-03 | 60 | 26 | 2 | C0021655 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 1.32e-03 | 61 | 26 | 2 | DOID:3021 (biomarker_via_orthology) | |
| Disease | HDL cholesterol change measurement, physical activity | 1.37e-03 | 62 | 26 | 2 | EFO_0003940, EFO_0007805 | |
| Disease | Autistic Disorder | 1.53e-03 | 261 | 26 | 3 | C0004352 | |
| Disease | Parkinson's disease (is_marker_for) | 1.59e-03 | 67 | 26 | 2 | DOID:14330 (is_marker_for) | |
| Disease | Manic Disorder | 1.79e-03 | 71 | 26 | 2 | C0024713 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.99e-03 | 286 | 26 | 3 | EFO_0004346, EFO_0006930 | |
| Disease | Depressive disorder | 2.05e-03 | 289 | 26 | 3 | C0011581 | |
| Disease | Manic | 2.15e-03 | 78 | 26 | 2 | C0338831 | |
| Disease | Depression, Bipolar | 2.21e-03 | 79 | 26 | 2 | C0005587 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.26e-03 | 80 | 26 | 2 | DOID:12930 (implicated_via_orthology) | |
| Disease | Ischemic stroke | 2.83e-03 | 324 | 26 | 3 | HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RVIILMVWIVSGLTS | 151 | P07550 | |
| ICIAFWGVRSMKQLT | 426 | Q6ZNB7 | |
| TMLVAKVTCIIIWLL | 141 | P30556 | |
| LKTLSVIMGVFVCCW | 271 | P21728 | |
| KTLSVIMGVFVCCWL | 296 | P21918 | |
| MHIWKVSRQCLLTLI | 396 | O75747 | |
| CITNPLWVTKTRLML | 136 | Q9H2D1 | |
| ALLRTCVKAMGIWVV | 156 | P28336 | |
| SKRVCVLMITGSWII | 136 | Q8NGY9 | |
| AAIWVTILCMARLKT | 616 | Q9HCN3 | |
| TIRMGTTLCLAVWLT | 146 | P51685 | |
| MKCTAREWLRVTTVL | 1 | Q9H336 | |
| CTKVPELIRTIMGWT | 126 | Q07812 | |
| MTVKRVGIIISCIWA | 161 | P32245 | |
| IGRVSLAAKSLCMWV | 3186 | Q9P225 | |
| WAMVTCNLSSKIIRV | 616 | Q86YC3 | |
| SGTTWMIEIICLILK | 71 | O00204 | |
| NMCALRILKTVSWLT | 276 | Q7RTX9 | |
| MRLGLCVVALVLSWT | 1 | Q2MKA7 | |
| IIRKVGWIMLVTTGS | 311 | Q9HAS3 | |
| WRMLLIVVSVCTATG | 31 | Q8N9A8 | |
| WKIGLMCFLSIIITT | 26 | Q6UVW9 | |
| MSCLGLLWIIKVSRA | 991 | Q6U841 | |
| CVASVVSVKGRLMWL | 426 | Q5VUG0 | |
| VVCVWELSMTKGRPR | 2956 | Q6ZS81 | |
| VGRCKLWMIITSIFL | 61 | Q5BVD1 | |
| KLSEIGTIAWMITLC | 296 | Q9C0K1 |